Neovasc Inc Asset Turnover Ratio (NVCN), as of fourth quarter 2021, current and historic results, rankings and more - CSIMarket
CSIMarket Company Name, Ticker, Industry, else..
 


• Sales per Employee
• Income per Employee
• Inventory Turnover
• Asset Turnover
• Receivables Turnover
Neovasc Inc   (NASDAQ: NVCN)
 

Neovasc Inc Asset Turnover Ratio

Quarterly Results, Trends, Rankings, Statistics

Neovasc Inc 's asset turnover ratio has remained unchanged compare to previous quarter at 0.04 in the fourth quarter (Dec 31 2021)

Within sector 170 more businesses have achieved higher asset turnover ratio. While ranking the asset turnover ratio, among all other companies, it is fair to say, that the company's position has deteriorated in the fourth quarter 2021 compared to the preceding quarter from 0 to 4115.

Asset Turnover Ratio Definition


Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

NVCN Asset Turnover Ratio (Dec 31 2021)
IV. Quarter		 0
III. Quarter		 0
II. Quarter		 0
I. Quarter		 (Dec 31 2019)
IV. Quarter
Y / Y Asset Change 321.72 % 482.44 % 555.31 % 555.31 % 59.73 %
Y / Y Revenue Change 21.77 % - - - 19.6 %
Asset Turnover Ratio (TTM) 0.04 - - - 0.18
NVCN's Total Ranking # 4115 # 0 # 4110 # 0 #
Seq. Asset Change 2.79 % 0 % 0 % 310.26 % 41.97 %
Seq. Revenue Change - - - - -



Asset Turnover Ratio Company Ranking
Within: No.
Medical Equipment & Supplies Industry # 171
Healthcare Sector # 619
Overall Market # 4115

Asset Turnover Ratio Statistics
High Average Low
0.21 0.13 0.04
(Dec 31 2019)   (Dec 31 2021)




NVCN Company Profile • Back to NVCN Efficiency Comparisons • Compare NVCN Asset Turnover Ratio to its Competitors



Companies with similar Asset Turnover Ratio for the quarter ending Dec 31 2021, within Healthcare Sector Asset Turnover Ratio Revenues for 12 Months ending Dec 31 2021 Assets at quarter ending Dec 31 2021
Inspiremd Inc   0.10 $ 4.495  Millions$ 44.332  Millions
Cyclo Therapeutics Inc   0.10 $ 1.586  Millions$ 15.751  Millions
Cytokinetics Incorporated  0.10 $ 70.428  Millions$ 702.555  Millions
Invitae Corporation  0.10 $ 460.449  Millions$ 4,714.846  Millions
Fulcrum Therapeutics Inc   0.10 $ 19.163  Millions$ 196.226  Millions
Dyadic International Inc   0.10 $ 2.404  Millions$ 24.973  Millions
C4 Therapeutics Inc   0.10 $ 45.785  Millions$ 479.276  Millions
Shattuck Labs Inc   0.09 $ 30.017  Millions$ 317.446  Millions
Aravive Inc   0.09 $ 7.442  Millions$ 79.269  Millions
Galapagos Nv  0.09 $ 543.028  Millions$ 5,816.339  Millions
Innate Pharma Sa  0.09 $ 27.667  Millions$ 299.596  Millions
Zai Lab Limited  0.09 $ 144.312  Millions$ 1,591.135  Millions
Timber Pharmaceuticals Inc   0.09 $ 0.887  Millions$ 9.980  Millions
Intelgenx Technologies Corp   0.09 $ 1.535  Millions$ 17.301  Millions
Agile Therapeutics Inc  0.09 $ 4.101  Millions$ 46.943  Millions
Arbutus Biopharma Corp  0.09 $ 10.988  Millions$ 129.045  Millions
Legend Biotech Corporation  0.08 $ 89.792  Millions$ 1,057.831  Millions
Zymeworks Inc   0.08 $ 39.717  Millions$ 472.380  Millions
Armata Pharmaceuticals Inc   0.08 $ 4.474  Millions$ 53.391  Millions
Inhibikase Therapeutics Inc   0.08 $ 3.101  Millions$ 37.357  Millions
Pulmatrix Inc   0.08 $ 5.169  Millions$ 62.462  Millions
Gyre Therapeutics Inc   0.08 $ 7.338  Millions$ 88.765  Millions
Eiger Biopharmaceuticals Inc   0.08 $ 12.142  Millions$ 149.758  Millions
Pacific Biosciences Of California Inc   0.08 $ 130.513  Millions$ 1,634.949  Millions
Nektar Therapeutics  0.08 $ 101.907  Millions$ 1,305.586  Millions
Concord Medical Services Holdings Ltd  0.08 $ 76.206  Millions$ 977.615  Millions
Ideaya Biosciences Inc   0.08 $ 27.941  Millions$ 358.822  Millions
Protagonist Therapeutics inc   0.08 $ 27.357  Millions$ 355.794  Millions
Finch Therapeutics Group Inc   0.08 $ 18.532  Millions$ 243.657  Millions
Inspira Technologies Oxy B H N Ltd  0.08 $ 1.951  Millions$ 25.870  Millions



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.